Sg Americas Securities, LLC Mersana Therapeutics, Inc. Transaction History

Sg Americas Securities, LLC

$27.6 Billion
Q3 2024

A detailed history of Sg Americas Securities, LLC transactions in Mersana Therapeutics, Inc. stock. As of the latest transaction made, Sg Americas Securities, LLC holds 87,233 shares of MRSN stock, worth $192,784. This represents 0.0% of its overall portfolio holdings.

Number of Shares

87,233

Previous 138,722 37.12%

Holding current value

$192,784

Previous $279,000 40.86%

% of portfolio

0.0%

Previous 0.0%

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 03, 2024	SELL	$1.23 - $2.25 $63,331 - $115,850	-51,489 Reduced 37.12%	87,233 $165,000
Q2 2024 Jul 12, 2024	BUY	$2.0 - $4.45 $210,418 - $468,180	105,209 Added 313.93%	138,722 $279,000
Q1 2024 May 06, 2024	SELL	$2.16 - $5.94 $12,340 - $33,935	-5,713 Reduced 14.56%	33,513 $150,000
Q4 2023 Jan 12, 2024	SELL	$1.11 - $2.34 $8,229 - $17,348	-7,414 Reduced 15.9%	39,226 $91,000
Q3 2023 Oct 13, 2023	BUY	$1.06 - $3.91 $49,438 - $182,362	46,640 New	46,640 $59,000
Q1 2023 Apr 28, 2023	SELL	$4.0 - $7.02 $9,304 - $16,328	-2,326 Reduced 4.75%	46,605 $192,000
Q4 2022 Feb 02, 2023	BUY	$5.65 - $7.86 $52,737 - $73,365	9,334 Added 23.57%	48,931 $287,000
Q3 2022 Oct 31, 2022	SELL	$4.63 - $8.0 $36,845 - $63,664	-7,958 Reduced 16.73%	39,597 $268,000
Q2 2022 Jul 29, 2022	BUY	$2.84 - $5.0 $135,056 - $237,775	47,555 New	47,555 $220,000
Q1 2022 Apr 29, 2022	SELL	$3.74 - $6.63 $60,823 - $107,823	-16,263 Closed	0 $0
Q4 2021 Feb 07, 2022	SELL	$5.48 - $9.86 $112,066 - $201,637	-20,450 Reduced 55.7%	16,263 $101,000
Q3 2021 Nov 01, 2021	BUY	$8.56 - $14.47 $314,263 - $531,237	36,713 New	36,713 $346,000
Q2 2021 Aug 12, 2021	SELL	$13.28 - $18.07 $165,946 - $225,802	-12,496 Closed	0 $0
Q1 2021 May 13, 2021	BUY	$15.31 - $26.52 $87,496 - $151,561	5,715 Added 84.28%	12,496 $202,000
Q4 2020 Feb 04, 2021	SELL	$16.84 - $27.59 $477,026 - $781,541	-28,327 Reduced 80.69%	6,781 $180,000
Q3 2020 Nov 09, 2020	BUY	$16.2 - $25.7 $294,111 - $466,583	18,155 Added 107.09%	35,108 $654,000
Q2 2020 Jul 20, 2020	BUY	$5.24 - $23.4 $21,253 - $94,910	4,056 Added 31.45%	16,953 $397,000
Q1 2020 Apr 30, 2020	BUY	$4.41 - $9.28 $56,875 - $119,684	12,897 New	12,897 $75,000

Others Institutions Holding MRSN

# of Institutions

121

Shares Held

116M

Call Options Held

233K

Put Options Held

457K

View Full List

About Mersana Therapeutics, Inc.

Ticker MRSN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 97,169,296
Market Cap $215M
Description
Mersana Therapeutics, Inc., a clinical stage biopharmaceutical company, develops antibody drug conjugates (ADC) for cancer patients with unmet need. It develops XMT-1592, a Dolasynthen ADC targeting NaPi2b-expressing tumor cells, which is in phase I clinical trial for the treatment of ovarian cancer and NSCLC adenocarcinoma. The company also dev...

More about MRSN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Sg Americas Securities, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Sg Americas Securities, LLC with notifications on news.

Account

Sg Americas Securities, LLC Mersana Therapeutics, Inc. Transaction History